Regulatory & Compliance Advisory
Navigate FDA, EFDA, and WHO expectations with clear regulatory mapping, compliance readiness, and governance support.
Calebyte BioSolutions
Overview
Clinical studies in Africa require approvals from national regulatory authorities and ethics committees, each with its own requirements and timelines. Navigating these well is essential to both study timelines and participant protection.
We help sponsors plan regulatory and ethics pathways, prepare high-quality submissions, and coordinate with review bodies throughout the life of the study, while strengthening research governance at participating institutions.
Challenges addressed
National authorities, institutional review boards, and ethics committees with differing processes.
Incomplete or poorly adapted dossiers that lead to queries and delays.
Amendments, safety reports, and renewals that must be managed throughout the study.
Institutions that need stronger oversight structures for sponsored research.
Capabilities
Plan the regulatory pathway, sequencing, and timelines for your study.
Prepare and adapt submission packages for national regulatory authorities.
Manage interactions, queries, and approvals with ethics committees.
Prepare protocols, consent forms, and supporting materials for IRB review.
Prepare sites and teams for inspections, audits, and ongoing compliance.
Strengthen oversight structures, policies, and accountability for research.
Our approach
Map regulatory and ethics requirements for each site.
Develop complete, locally adapted submission packages.
Manage review, queries, and approvals with each body.
Handle amendments, renewals, and ongoing reporting.
Benefits
Submissions prepared for local expectations.
Ethics oversight built into study design.
Teams and documents prepared for scrutiny.
Governance that supports future research.
Related services
Navigate FDA, EFDA, and WHO expectations with clear regulatory mapping, compliance readiness, and governance support.
End-to-end operational support from feasibility and site identification through study start-up, monitoring, and coordination.
Safety reporting, adverse event documentation, and pharmacovigilance processes that protect participants and meet reporting obligations.
Tell us about your goals and we will help you identify the right next step.